Upstream Processing: Regulatory Considerations Regarding Quality Aspects of Monoclonal Antibodies - An alternative to the hybridoma method is producing engineered antibody molecules and fragments

ADVERTISEMENT

Upstream Processing: Regulatory Considerations Regarding Quality Aspects of Monoclonal Antibodies
An alternative to the hybridoma method is producing engineered antibody molecules and fragments by in vitro methods.


BioPharm International
Volume 20, Issue 7

35. http:// http://www.emea.eu.int/humandocs/Humans/EPAR/synagis/Synagis.htm [Accessed 2005 Oct 15].

36. http:// http://www.ebra.org/ebrabulletin-ecvam-report-monoclonal-antibody-production_76.htm [Accessed 2005 Sept 22].

37. http:// http://www.emea.info/humandocs/Humans/EPAR/leukoscan/leukoscan.htm; [Accessed 2005 Sept 23].

38. http:// http://www.emea.info/humandocs/PDFs/EPAR/Ceascan/041296en6.pdf; [Accessed 2005 Sept 22].

39. Marx U, Embleton MJ, Fischer R. Monoclonal antibody production. The report and recommendations of ECVAM workshop 23. 1997 ATLA 25:121-135.

40. Werner RG. The development and production of biopharmaceuticals. Bioprocess International 2005 Supplement to Vol. 3; 9:6-15.

41. http:// http://www.emea.eu.int/humandocs/Humans/EPAR/enbrel/enbrel.htm [Accessed 2005 Oct 11].

42. http:// http://www.emea.eu.int/humandocs/Humans/EPAR/humira/humira.htm; [Accessed 2005 Oct 14].

43. http:// http://www.emea.eu.int/humandocs/Humans/EPAR/herceptin/herceptin.htm; [Accessed 2005 Oct 15]

44. http:// http://www.preclinica.com/content/articles/frame.asp?issue=0304&article=12; [Accessed 2006, Oct 12]


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

EMA Warns of Falsified Herceptin Vials
April 16, 2014
Mallinckrodt to Acquire Questcor Pharmaceuticals
April 16, 2014
American CryoStem and Rutgers University File Joint Patent on Stem Cell Platform
April 11, 2014
Center for Biologics Evaluation and Research Relocates
April 11, 2014
PhRMA Report Reveals Growth Trajectories and Policy Factors Affecting Biopharmaceutical Growth
April 11, 2014
Author Guidelines
Source: BioPharm International,
Click here